BR0014591A - Cloridrato polimórfico de n-[3-[[2-(3, 4-dimetoxifenil) etil] amino ]propil]-4-nitro benzamida - Google Patents
Cloridrato polimórfico de n-[3-[[2-(3, 4-dimetoxifenil) etil] amino ]propil]-4-nitro benzamidaInfo
- Publication number
- BR0014591A BR0014591A BR0014591-2A BR0014591A BR0014591A BR 0014591 A BR0014591 A BR 0014591A BR 0014591 A BR0014591 A BR 0014591A BR 0014591 A BR0014591 A BR 0014591A
- Authority
- BR
- Brazil
- Prior art keywords
- polymorphic
- dimethoxyphenyl
- propyl
- ethyl
- amino
- Prior art date
Links
- QLUVAVFNMRXIIZ-UHFFFAOYSA-N n-[3-[2-(3,4-dimethoxyphenyl)ethylamino]propyl]-4-nitrobenzamide;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCNCCCNC(=O)C1=CC=C([N+]([O-])=O)C=C1 QLUVAVFNMRXIIZ-UHFFFAOYSA-N 0.000 title 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 abstract 2
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9923933.7A GB9923933D0 (en) | 1999-10-08 | 1999-10-08 | Novel pharmaceutical |
| PCT/GB2000/003847 WO2001027071A1 (en) | 1999-10-08 | 2000-10-06 | Polymorphic n-[3-[[2-(3,4-dimethoxyphenyl) ethyl] amino] propyl] -4-nitro benzamide hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0014591A true BR0014591A (pt) | 2002-06-11 |
Family
ID=10862442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0014591-2A BR0014591A (pt) | 1999-10-08 | 2000-10-06 | Cloridrato polimórfico de n-[3-[[2-(3, 4-dimetoxifenil) etil] amino ]propil]-4-nitro benzamida |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1218334A1 (xx) |
| JP (1) | JP2003511437A (xx) |
| KR (1) | KR20020043618A (xx) |
| CN (1) | CN1384817A (xx) |
| AU (1) | AU7546000A (xx) |
| BR (1) | BR0014591A (xx) |
| CA (1) | CA2386845A1 (xx) |
| CZ (1) | CZ20021189A3 (xx) |
| GB (1) | GB9923933D0 (xx) |
| HK (1) | HK1049147A1 (xx) |
| HU (1) | HUP0203582A2 (xx) |
| IL (1) | IL148966A0 (xx) |
| MX (1) | MXPA02003516A (xx) |
| NO (1) | NO20021639L (xx) |
| PL (1) | PL354137A1 (xx) |
| TR (1) | TR200200949T2 (xx) |
| WO (1) | WO2001027071A1 (xx) |
| ZA (1) | ZA200202679B (xx) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7227033B2 (en) | 2002-01-09 | 2007-06-05 | Emisphere Technologies, Inc. | Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate |
| AU2007330478B2 (en) * | 2006-12-06 | 2011-09-08 | Conatus Pharmaceuticals, Inc. | Crystalline forms of ( 3 S ) -3- [N- (N' - (2-tert-butylphenyl) oxamyl) alaninyl] amino-5- (2 ', 3 ', 5 ', 6 ' -tetrafluorophenoxy) -4-oxopentanoic acid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2726267B1 (fr) * | 1994-10-26 | 1998-01-02 | Smithkline Beecham Lab | Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer |
| GB9706376D0 (en) * | 1997-03-27 | 1997-05-14 | Smithkline Beecham Plc | Novel pharmaceutical |
-
1999
- 1999-10-08 GB GBGB9923933.7A patent/GB9923933D0/en not_active Ceased
-
2000
- 2000-10-06 HU HU0203582A patent/HUP0203582A2/hu unknown
- 2000-10-06 KR KR1020027004451A patent/KR20020043618A/ko not_active Application Discontinuation
- 2000-10-06 EP EP00964535A patent/EP1218334A1/en not_active Withdrawn
- 2000-10-06 WO PCT/GB2000/003847 patent/WO2001027071A1/en active IP Right Grant
- 2000-10-06 MX MXPA02003516A patent/MXPA02003516A/es unknown
- 2000-10-06 PL PL00354137A patent/PL354137A1/xx not_active Application Discontinuation
- 2000-10-06 AU AU75460/00A patent/AU7546000A/en not_active Abandoned
- 2000-10-06 IL IL14896600A patent/IL148966A0/xx unknown
- 2000-10-06 JP JP2001530092A patent/JP2003511437A/ja active Pending
- 2000-10-06 CN CN00813990A patent/CN1384817A/zh active Pending
- 2000-10-06 CZ CZ20021189A patent/CZ20021189A3/cs unknown
- 2000-10-06 TR TR2002/00949T patent/TR200200949T2/xx unknown
- 2000-10-06 BR BR0014591-2A patent/BR0014591A/pt not_active Application Discontinuation
- 2000-10-06 CA CA002386845A patent/CA2386845A1/en not_active Abandoned
-
2002
- 2002-04-05 NO NO20021639A patent/NO20021639L/no not_active Application Discontinuation
- 2002-04-05 ZA ZA200202679A patent/ZA200202679B/en unknown
- 2002-12-27 HK HK02109370.9A patent/HK1049147A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0203582A2 (en) | 2004-03-01 |
| KR20020043618A (ko) | 2002-06-10 |
| PL354137A1 (en) | 2003-12-29 |
| CA2386845A1 (en) | 2001-04-19 |
| NO20021639L (no) | 2002-05-30 |
| ZA200202679B (en) | 2003-05-28 |
| GB9923933D0 (en) | 1999-12-08 |
| TR200200949T2 (tr) | 2002-08-21 |
| CN1384817A (zh) | 2002-12-11 |
| EP1218334A1 (en) | 2002-07-03 |
| JP2003511437A (ja) | 2003-03-25 |
| CZ20021189A3 (cs) | 2002-09-11 |
| MXPA02003516A (es) | 2004-09-10 |
| HK1049147A1 (zh) | 2003-05-02 |
| IL148966A0 (en) | 2002-11-10 |
| NO20021639D0 (no) | 2002-04-05 |
| WO2001027071A1 (en) | 2001-04-19 |
| AU7546000A (en) | 2001-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR045317A1 (es) | Forma cristalina de agonista dl receptor adrenergico b2 | |
| AR040661A1 (es) | Diclorhidrato cristalino de n-{2-[-((r)-2-hidroxi-2-feniletilamino)fenil]etil}-(r)-2hidroxi-2-(3-formamido-4-hidroxifenil)etilamina, agonista del receptor adrenergico beta 2 | |
| BR0008753B1 (pt) | Composto de amida, processo para preparar um composto de amida, composição farmacêutica e uso de um composto de amida | |
| BR0307529A (pt) | Derivados de n-fenil-2-pirimidina-amina | |
| PT1401445E (pt) | Anticolinergico cristalino, processo para a sua preparacao e sua utilizacao para a preparacao de um medicamento | |
| BR9910913A (pt) | Composto, processo para a preparação de um composto, formulação farmacêutica, uso de um composto, e, processo para a profilaxia e/ou tratamento de condições clìnicas associadas com resistência a insulina | |
| MY117971A (en) | Denaturants for sympathomimetic amine salts | |
| BR0115482A (pt) | Composição de sacralose melhorada e processo para sua preparação | |
| BR9911182B1 (pt) | compostos derivados de biarila com propriedades agonistas de adrenorreceptores beta-3, uso de um composto, composição farmacêutica, e, processo para a preparação de um composto. | |
| PT973511E (pt) | Utilizacao de analogos de sibutramina para baixar os niveis de lipidos | |
| IS1954B (is) | Alfa-hýdroxý, -amínó- og -flúoró afleiður beta-súlfonýlhýdroxamsýra notaðar sem tálmar við grindarmálmprótínkljúfum | |
| BR0211691A (pt) | Processo para a prepara de tolterodina | |
| IT1319671B1 (it) | Processo per la preparazione di (s)-n,n'-bis(2-idrossi-1-(idrossimetil)etil)-5-((2-idrossi-1-ossopropil)ammino) | |
| PL361705A1 (en) | Process for the preparation of n-(substituted phenyl)-3-alkyl-, aryl- and heteroarylsulfonyl-2-hydroxy-2-alkyl- and haloalkylpropanamide compounds | |
| BR0014591A (pt) | Cloridrato polimórfico de n-[3-[[2-(3, 4-dimetoxifenil) etil] amino ]propil]-4-nitro benzamida | |
| BR0111193A (pt) | Nova forma amorfa de hidrocloreto de sertralina e processo de preparação da mesma. | |
| BR9810405A (pt) | Composição que compreende 5-[4-[2-(n-metil-n-2-piridil) amino) etoxi] benzil] tiazolidino-2,4-diona | |
| BR9608820A (pt) | Processo para a preparação de monoidrato de cloridreto de ropivacaína e monoidrato de cloridreto de ropivacaína | |
| EE200200583A (et) | (E)-N-(6,6-dimetüül-2-hepteen-4-ünüül)-N-metüül-1-naftaleenmetaanamiini (terbinafiin) valmistamise meetod | |
| PT1235788E (pt) | Processo para a preparacao de derivados de ariletanolamina com propriedades anti-obesidade e anti-diabeticas | |
| BR0113713A (pt) | Sal de cloridrato de 5-[4-[2-(metil-n-(2-piridil)amino)etóxi]benzil]tiazolidina -2,4-diona | |
| ITMI981996A0 (it) | Processo per la preparazione della s-n,n'-bis[2-idrossi-1- (idrossimetil)etil]-5-[(2-idrossi-1-ossopropil)ammino]-2,4,6-triiodo- | |
| BG105999A (en) | Treatment of osteoarthritis | |
| BR9608332A (pt) | Derivados de 1-(w-Ú3,4-dihidro-2-naftalenil)aquil¾ amina cíclica processo para a preparaç o dos mesmos e composiç o farmacêutica contendo os mesmos | |
| HUP0200034A2 (hu) | Eljárás midodrin előállítására és intermedierje |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |